Skip to main content

Table 1 Patients' characteristics.

From: Efficacy of sorafenib on metastatic renal cell carcinoma in Asian patients: Results from a multicenter study

Characteristic No. patients (%)
Age, y  
   >= 60 26 (26.5)
   <60 72 (73.5)
Sex  
   Male 73 (74.5)
   Female 25 (25.5)
T-classification at initial diagnosis  
   T1 19 (19.4)
   T2 30 (30.6)
   T3 42 (42.9)
   T4 7 (7.1)
AJCC staging group at initial diagnosis  
   I 11 (11.2)
   II 24 (24.5)
   III 18 (18.4)
   IV 45 (45.9)
Fuhrman grade  
   1 4 (4.1)
   2 49 (50.0)
   3 39 (39.8)
   4 6 (6.1)
Histology  
   Predominant clear cell 87 (88.8)
   Non-clear cell 11 (11.2)
Sites of metastatic diseases  
   Lung 70 (71.4)
   Liver 10 (10.2)
   Bone 18 (18.4)
   Lymph node 24 (24.5)
   Adrenal gland 12 (12.2)
   Other 12 (12.2)
Number of metastatic foci  
   1 20 (20.4)
   2 29 (29.6)
   3 21 (21.4)
   >= 4 28 (28.6)
ECOG performance status  
   0 56 (57.1)
   1 37 (37.8)
   2 4 (4.1)
   3 1 (1.0)